Clinical trial
A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the…
NCT00253123 · Janssen, LP, Industry · Completed
Key facts
| NCT number | NCT00253123 |
|---|---|
| Title | A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Behavioral Disturbances in Patients With Dementia |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Study of Risperidone for Treatment of Behavioral Disturbances in Subjects With Dementia |
| Lead sponsor | Janssen, LP, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Dementia, Alzheimer Disease, Vascular |
| Intervention type | Drug |
| Interventions | risperidone |
| Enrollment | 626 |
| Completion | Mar 1, 1997 |
| First posted | Nov 15, 2005 |
| Last update posted | Dec 3, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: